Dr. Peterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
711 Medical Village Dr
Edgewood, KY 41017Phone+1 859-331-0774- Is this information wrong?
Education & Training
- Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2016 - 2019
- Duke University HospitalResidency, Internal Medicine, 2013 - 2016
- University of Rochester School of Medicine and DentistryClass of 2013
Certifications & Licensure
- KY State Medical License 2022 - 2025
- IN State Medical License 2022 - 2025
- MA State Medical License 2016 - 2023
- RI State Medical License 2021 - 2022
- NC State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION.Benjamin E Peterson, Robert A Harrington, Gregg W Stone, Ph Gabriel Steg, C Michael Gibson, Christian W Hamm, Matthew J Price, Renato D Lopes, Sergio Leonardi, Jayne P...> ;Circulation. Cardiovascular Interventions. 2022 Mar 1
- 4 citationsEvaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial.Benjamin E Peterson, Deepak L. Bhatt, Ph. Gabriel Steg, Jonas Oldgren, Michael Maeng, Uwe Zeymer, Sigrun Halvorsen, Stefan H. Hohnloser, Gregory Y.H. Lip, Takeshi Kimu...> ;JACC. Cardiovascular Interventions. 2021 Apr 12
- 1 citationsThe Emerging Role of Coronary Computed Tomography Angiography in Stable Angina With ISCHEMIA.Deepak L. Bhatt, Benjamin E Peterson> ;JACC. Cardiovascular Imaging. 2021 Mar 10
- Join now to see all
Press Mentions
- Addition of Icosapent Ethyl Cuts CV Risk in Patients with Prior PCIMarch 24th, 2022
- Amarin’s Vascepa Shows Lower Risk of Fatal CV Events in REDUCE-IT Prior PCI Post Hoc SubanalysisMarch 10th, 2022
- REDUCE-IT: Significant Reduction in Coronary Revascularizations with Icosapent EthylMay 15th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: